• Biotech IPO freeze continues as second quarter is slowest in more than a decade

    1 month ago - By MedCity News

    Summer weather is heating up but the market for IPOs remains cold. Bausch + Lomb's successful return to the public markets in the second quarter proved to be an exception as the slowdown in IPO activity reached levels not seen in years.
    Read more ...